Improving Asthma Care for Patients and the Environment
Asthma outcomes in the UK are worse than the European average. Our treatment of asthma in the UK relies too heavily on short-acting beta agonists and, unlike many of our European neighbours, most of the SABA we prescribe is in the form of pMDI inhalers.
This type of inhaler is much more damaging to the environment than DPI inhalers and there is rarely a clinical indication for choosing a pMDI over a DPI.
NHS Scotland's Climate Emergency and Sustainability Strategy identified pMDIs as having a greater carbon footprint than the entire NHS Scotland vehicle fleet. They propose a target of a 70% reduction in pMDI inhalers by 2028.
To do this, we need to focus on: improving the quality of Asthma care; a migration to DPI inhalers, where clinically appropriate; and the correct disposal of used inhalers.
This one off education session is supported by ECHO in Highland and this will be considered along with other formats for potential future sessions.
We’re looking forward to welcoming you for what we hope will be an enjoyable experience.
Registrations should be received by 20/03/23 via the link below. We will contact you with your joining details soon after this date. Please also check your spam or junk mail folder emails for further communication.
If you would like more information about registering, contact firstname.lastname@example.org .
Please support your Highland Hospice
Registered Office: Highland Hospice, Ness House, 1 Bishops Road, Inverness IV3 5SB.
Telephone: 01463 243132. Email: email@example.com
Highland Hospice is a registered Scottish charity, no. SC011227 and a company limited by guarantee, no. SC093464
Website by dynam